AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2015
Aug 20, 2015
34301_dirs_2015-08-20_4c7949a0-d168-4331-a00d-abab3946b339.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-08-19
Reporting Person: KESTEN STEVEN (Exec VP and Chief MO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-19 | Common Stock | P | 6000 | $0.3871 | Acquired | 6000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2201 | Direct |
Footnotes
F1: Steven Kesten and Barbara Mary Kesten, trustees of The Kesten Living Trust Dated January 31, 2002.
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
Jun 18
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Call Transcript
2026
May 14
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9